US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cadrenal Therapeutics, Inc.

0.9723

-0.0177-1.79%

Pre-market: 0.9175-0.0548-5.64%06:30 EDT

Volume:1.79M

Turnover:1.83M

Market Cap:3.47M

PE:-0.20

High:1.07

Open:1.01

Low:0.9169

Close:0.9900

52wk High:14.50

52wk Low:0.8500

Shares:3.57M

Float Shares:3.22M

Volume Ratio:20.08

T/O Rate:55.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8667

EPS(LYR):-6.6394

ROE:-275.16%

ROA:-125.93%

PB:0.85

PE(LYR):-0.15

Loading ...

Overview Company News Filings

Cadrenal Therapeutics Chairman, CEO Quang X. Pham disposes of USD 70,947 in common shares

Cadrenal Therapeutics to initiate CAD-1005 trial

Cadrenal Therapeutics plans Phase 2a trial of CAD-1005 to prevent acute kidney injury in high-risk cardiac surgery patients

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (Csa-Aki) Clinical Plan to Accelerate Pharma Partnering at Upcoming Bio 2026

THOMSON REUTERS

Cadrenal Therapeutics - to Initiate Phase 2a Trial of CAD-1005 for Aki in Cardiac Surgery Patients

THOMSON REUTERS

Cadrenal Therapeutics - Phase 2a Trial Expected to Begin Later This Year

THOMSON REUTERS

Cadrenal Therapeutics CEO Quang X. Pham disposes of $90,610 common shares

Cadrenal CEO, Chairman Quang X. Pham sells USD 36,071 of common shares

BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing

Cadrenal Therapeutics - Appoints Quang X. Pham as Interim CFO and Interim Principal Accounting Officer - SEC Filing

THOMSON REUTERS

Cadrenal Therapeutics - Matthew K. Szot Steps Down as CFO Effective May 28, 2026 - SEC Filing

THOMSON REUTERS

Cadrenal Therapeutics names CEO Quang X. Pham interim CFO after Matthew Szot exit

Cadrenal Therapeutics to attend BIO International Convention 2026 partnering event

Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 3,057.57 in common shares

Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 69,363 of common shares

Cadrenal Therapeutics CEO, Chairman Quang Pham sells 1,165 common shares for $6,628.85

Cadrenal Therapeutics to present at Lytham Partners Spring 2026 Investor Conference

Cadrenal Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Press Release: Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA

Cadrenal Therapeutics Inc expected to post a loss of $1.62 a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CVKD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CVKD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","market":"US","secType":"STK","nameCN":"Cadrenal Therapeutics, Inc.","latestPrice":0.9723,"timestamp":1791403200000,"preClose":0.99,"halted":0,"volume":1787821,"hourTrading":{"tag":"盘前","latestPrice":0.9175,"preClose":0.9723,"latestTime":"06:30 EDT","volume":1165,"amount":1066.121091,"timestamp":1791455422169,"change":-0.0548,"changeRate":-0.056361,"amplitude":0.036511},"delay":0,"changeRate":-0.017878787878787817,"floatShares":3223023,"shares":3567600,"eps":-4.866724,"marketStatus":"Pre-Mkt","change":-0.0177,"latestTime":"10-08 06:32:13 EDT","open":1.01,"high":1.07,"low":0.9169,"amount":1827086.1974946,"amplitude":0.154646,"askPrice":0.94,"askSize":100,"bidPrice":0.915,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-4.866724,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1674190800000,"exchange":"NASDAQ","adjPreClose":0.9723,"preHourTrading":{"tag":"盘前","latestPrice":0.9175,"preClose":0.9723,"latestTime":"06:30 EDT","volume":1165,"amount":1066.121091,"timestamp":1791455422169,"change":-0.0548,"changeRate":-0.056361,"amplitude":0.036511},"postHourTrading":{"tag":"盘后","latestPrice":0.9403,"preClose":0.9723,"latestTime":"19:30 EDT","volume":7218,"amount":6957.3415,"timestamp":1791415847031,"change":-0.032,"changeRate":-0.032912,"amplitude":0.071994},"volumeRatio":20.08453649727308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVKD\",,,,,undefined,":{"symbol":"CVKD","floatShares":3223023,"roa":"-125.93%","roe":"-275.16%","lyrEps":-6.639405,"volumeRatio":20.08453649727308,"shares":3567600,"dividePrice":0,"high":1.07,"amplitude":0.154646,"preClose":0.99,"low":0.9169,"week52Low":0.85,"pbRate":"0.85","week52High":14.4999,"institutionHeld":0,"latestPrice":0.9723,"committee":0.5,"eps":-4.866724,"divideRate":0,"volume":1787821,"delay":0,"ttmEps":-4.866724,"open":1.01,"prevYearClose":6.78,"prevWeekClose":0.9402,"prevMonthClose":1.08,"prevQuarterClose":1.08,"fiveDayClose":1.08,"twentyDayClose":1.19,"sixtyDayClose":2.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVKD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"CVKD","fiscalQuarterEnding":"2026/06","expectedEps":-1.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2026-05-07","symbol":"CVKD","fiscalQuarterEnding":"2026/03","expectedEps":-1.51,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2026-03-31","symbol":"CVKD","fiscalQuarterEnding":"2025/12","expectedEps":-1.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-11-10","symbol":"CVKD","fiscalQuarterEnding":"2025/09","expectedEps":-1.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.31},{"market":"US","date":"2025-08-11","symbol":"CVKD","fiscalQuarterEnding":"2025/06","expectedEps":-1.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.87}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVKD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVKD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775620800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVKD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVKD","date":"2026-10-07","current":-0.199785,"percent":0.996663,"low":-6.5442,"twenty":-2.463463,"median":-1.430392,"eighty":-0.789454,"high":-0.290567,"avg":-1.723517,"sd":1.095279,"marketCap":3531916},"quantilePoints":[{"date":"2023-01-20","current":-6.5442,"twenty":-6.16384,"median":-5.593301,"eighty":-5.593301,"marketCap":47934449},{"date":"2023-01-27","current":-4.161603,"twenty":-5.973233,"median":-5.338088,"eighty":-4.549173,"marketCap":30482586},{"date":"2023-02-03","current":-3.812156,"twenty":-5.593301,"median":-4.511051,"eighty":-4.113951,"marketCap":27922980},{"date":"2023-02-10","current":-3.160912,"twenty":-5.38913,"median":-4.288675,"eighty":-3.488122,"marketCap":23152804},{"date":"2023-02-17","current":-3.573896,"twenty":-4.892266,"median":-4.082183,"eighty":-3.392818,"marketCap":26177793},{"date":"2023-02-24","current":-3.345166,"twenty":-4.587294,"median":-3.573896,"eighty":-3.380111,"marketCap":24502414},{"date":"2023-03-03","current":-2.875001,"twenty":-4.507652,"median":-3.569925,"eighty":-3.160912,"marketCap":21058580},{"date":"2023-03-10","current":-2.589089,"twenty":-4.478393,"median":-3.494476,"eighty":-3.058111,"marketCap":18964357},{"date":"2023-03-17","current":-2.271409,"twenty":-4.364918,"median":-3.399172,"eighty":-2.900415,"marketCap":16637442},{"date":"2023-03-24","current":-1.985498,"twenty":-4.145719,"median":-3.271465,"eighty":-2.525553,"marketCap":14543218},{"date":"2023-03-31","current":-2.239641,"twenty":-4.082183,"median":-3.15297,"eighty":-2.291105,"marketCap":16404750},{"date":"2023-04-06","current":-2.112569,"twenty":-4.082183,"median":-3.137086,"eighty":-2.249171,"marketCap":15473984},{"date":"2023-04-12","current":-2.229793,"twenty":-4.028178,"median":-3.11326,"eighty":-2.242818,"marketCap":16332616},{"date":"2023-04-21","current":-2.446133,"twenty":-3.866161,"median":-3.03114,"eighty":-2.237671,"marketCap":17917245},{"date":"2023-04-28","current":-2.366713,"twenty":-3.6692,"median":-2.946479,"eighty":-2.249171,"marketCap":17335516},{"date":"2023-05-05","current":-2.096686,"twenty":-3.573896,"median":-2.875001,"eighty":-2.188781,"marketCap":15357639},{"date":"2023-05-12","current":-1.444685,"twenty":-3.573896,"median":-2.612915,"eighty":-2.169752,"marketCap":17800899},{"date":"2023-05-19","current":-1.359704,"twenty":-3.569131,"median":-2.462017,"eighty":-2.077625,"marketCap":16753788},{"date":"2023-05-26","current":-1.284383,"twenty":-3.546035,"median":-2.446133,"eighty":-1.985498,"marketCap":15825717},{"date":"2023-06-02","current":-1.346224,"twenty":-3.517444,"median":-2.384186,"eighty":-1.928316,"marketCap":16587696},{"date":"2023-06-09","current":-1.503204,"twenty":-3.469062,"median":-2.334945,"eighty":-1.45944,"marketCap":18521951},{"date":"2023-06-16","current":-1.44612,"twenty":-3.43094,"median":-2.283322,"eighty":-1.45944,"marketCap":17818586},{"date":"2023-06-23","current":-1.484176,"twenty":-3.418233,"median":-2.263467,"eighty":-1.465148,"marketCap":18287496},{"date":"2023-06-30","current":-1.398551,"twenty":-3.367404,"median":-2.247583,"eighty":-1.465148,"marketCap":17232448},{"date":"2023-07-07","current":-1.417578,"twenty":-3.349614,"median":-2.226775,"eighty":-1.445833,"marketCap":17466903},{"date":"2023-07-14","current":-1.503299,"twenty":-3.286205,"median":-2.191989,"eighty":-1.443298,"marketCap":18523123},{"date":"2023-07-21","current":-1.637011,"twenty":-3.183023,"median":-2.150431,"eighty":-1.445833,"marketCap":20170670},{"date":"2023-07-28","current":-1.152922,"twenty":-3.160912,"median":-2.112569,"eighty":-1.436606,"marketCap":14205899},{"date":"2023-08-04","current":-1.14188,"twenty":-3.148205,"median":-2.045063,"eighty":-1.406161,"marketCap":14069843},{"date":"2023-08-11","current":-0.924489,"twenty":-3.132321,"median":-1.985498,"eighty":-1.379336,"marketCap":11854271},{"date":"2023-08-18","current":-0.791165,"twenty":-3.116437,"median":-1.961672,"eighty":-1.351057,"marketCap":10144725},{"date":"2023-08-25","current":-0.756633,"twenty":-3.058111,"median":-1.906237,"eighty":-1.33893,"marketCap":9701938},{"date":"2023-09-01","current":-0.782025,"twenty":-3.028503,"median":-1.714964,"eighty":-1.314525,"marketCap":10027520},{"date":"2023-09-08","current":-0.93325,"twenty":-2.992542,"median":-1.675857,"eighty":-1.277692,"marketCap":11966608},{"date":"2023-09-15","current":-0.791064,"twenty":-2.948067,"median":-1.596605,"eighty":-1.146297,"marketCap":10143423},{"date":"2023-09-22","current":-0.685541,"twenty":-2.919476,"median":-1.522232,"eighty":-1.104853,"marketCap":8790358},{"date":"2023-09-29","current":-0.680463,"twenty":-2.884531,"median":-1.503251,"eighty":-0.944749,"marketCap":8725245},{"date":"2023-10-06","current":-0.665229,"twenty":-2.792404,"median":-1.503204,"eighty":-0.904366,"marketCap":8529903},{"date":"2023-10-13","current":-0.649081,"twenty":-2.655802,"median":-1.479419,"eighty":-0.871399,"marketCap":8322842},{"date":"2023-10-20","current":-0.597183,"twenty":-2.61768,"median":-1.473616,"eighty":-0.791104,"marketCap":7657379},{"date":"2023-10-27","current":-0.503746,"twenty":-2.598619,"median":-1.465148,"eighty":-0.784463,"marketCap":6459285},{"date":"2023-11-03","current":-0.446871,"twenty":-2.525553,"median":-1.450877,"eighty":-0.769227,"marketCap":5730011},{"date":"2023-11-10","current":-0.446511,"twenty":-2.471547,"median":-1.444685,"eighty":-0.749525,"marketCap":5730011},{"date":"2023-11-17","current":-0.457674,"twenty":-2.462017,"median":-1.436606,"eighty":-0.722103,"marketCap":5873262},{"date":"2023-11-22","current":-0.507704,"twenty":-2.455663,"median":-1.417578,"eighty":-0.721088,"marketCap":6515283},{"date":"2023-12-01","current":-0.466807,"twenty":-2.446133,"median":-1.403307,"eighty":-0.699922,"marketCap":5990466},{"date":"2023-12-08","current":-0.471881,"twenty":-2.427072,"median":-1.388031,"eighty":-0.680463,"marketCap":6055580},{"date":"2023-12-15","current":-0.559052,"twenty":-2.387045,"median":-1.376708,"eighty":-0.648167,"marketCap":7174222},{"date":"2023-12-22","current":-0.56514,"twenty":-2.368619,"median":-1.351076,"eighty":-0.63015,"marketCap":7252358},{"date":"2023-12-29","current":-0.722638,"twenty":-2.366713,"median":-1.348603,"eighty":-0.629682,"marketCap":9273503},{"date":"2024-01-05","current":-0.635264,"twenty":-2.347652,"median":-1.341467,"eighty":-0.629743,"marketCap":8152244},{"date":"2024-01-12","current":-0.620651,"twenty":-2.315884,"median":-1.326907,"eighty":-0.629682,"marketCap":7964716},{"date":"2024-01-19","current":-0.953911,"twenty":-2.296823,"median":-1.312673,"eighty":-0.629723,"marketCap":12241388},{"date":"2024-01-26","current":-1.319238,"twenty":-2.284116,"median":-1.293897,"eighty":-0.63015,"marketCap":16929580},{"date":"2024-02-02","current":-1.430866,"twenty":-2.276174,"median":-1.320586,"eighty":-0.632524,"marketCap":18362083},{"date":"2024-02-09","current":-0.923467,"twenty":-2.265055,"median":-1.321934,"eighty":-0.637094,"marketCap":11850706},{"date":"2024-02-16","current":-0.791644,"twenty":-2.255525,"median":-1.298654,"eighty":-0.640854,"marketCap":10159050},{"date":"2024-02-23","current":-0.743847,"twenty":-2.252348,"median":-1.278807,"eighty":-0.643003,"marketCap":9545678},{"date":"2024-03-01","current":-0.714418,"twenty":-2.237671,"median":-1.221262,"eighty":-0.639426,"marketCap":9168018},{"date":"2024-03-08","current":-0.654241,"twenty":-2.228586,"median":-1.149822,"eighty":-0.640346,"marketCap":8395769},{"date":"2024-03-15","current":-1.139373,"twenty":-2.218452,"median":-1.14188,"eighty":-0.642618,"marketCap":9521837},{"date":"2024-03-22","current":-1.2068,"twenty":-2.196183,"median":-1.140626,"eighty":-0.643971,"marketCap":10085335},{"date":"2024-03-28","current":-1.225937,"twenty":-2.191989,"median":-1.148028,"eighty":-0.645513,"marketCap":10245260},{"date":"2024-04-05","current":-1.16485,"twenty":-2.176105,"median":-1.152922,"eighty":-0.647557,"marketCap":9734749},{"date":"2024-04-12","current":-0.835183,"twenty":-2.160222,"median":-1.146113,"eighty":-0.649081,"marketCap":6979692},{"date":"2024-04-19","current":-0.823306,"twenty":-2.140639,"median":-1.139373,"eighty":-0.654241,"marketCap":6880439},{"date":"2024-04-26","current":-0.81143,"twenty":-2.128453,"median":-1.124432,"eighty":-0.658604,"marketCap":6781187},{"date":"2024-05-03","current":-0.890734,"twenty":-2.112569,"median":-1.111003,"eighty":-0.664084,"marketCap":7443938},{"date":"2024-05-10","current":-0.929811,"twenty":-2.096686,"median":-1.0981,"eighty":-0.664287,"marketCap":7770510},{"date":"2024-05-17","current":-1.420575,"twenty":-2.049034,"median":-1.111003,"eighty":-0.665229,"marketCap":6885242},{"date":"2024-05-24","current":-1.383913,"twenty":-2.041092,"median":-1.124432,"eighty":-0.669767,"marketCap":6707548},{"date":"2024-05-31","current":-1.354187,"twenty":-2.034738,"median":-1.135559,"eighty":-0.672852,"marketCap":6563472},{"date":"2024-06-07","current":-1.651117,"twenty":-1.995028,"median":-1.145503,"eighty":-0.674597,"marketCap":8002633},{"date":"2024-06-14","current":-1.462522,"twenty":-1.985498,"median":-1.149334,"eighty":-0.676934,"marketCap":7088550},{"date":"2024-06-21","current":-1.516029,"twenty":-1.985498,"median":-1.156171,"eighty":-0.679183,"marketCap":7347887},{"date":"2024-06-28","current":-1.504138,"twenty":-1.985498,"median":-1.16485,"eighty":-0.680036,"marketCap":7290256},{"date":"2024-07-05","current":-1.592623,"twenty":-1.956907,"median":-1.185729,"eighty":-0.680463,"marketCap":7719123},{"date":"2024-07-12","current":-1.549057,"twenty":-1.928316,"median":-1.2068,"eighty":-0.68257,"marketCap":7507971},{"date":"2024-07-15","current":-1.520322,"twenty":-1.925139,"median":-1.2068,"eighty":-0.683272,"marketCap":7368698},{"date":"2024-08-02","current":-1.416942,"twenty":-1.921962,"median":-1.214031,"eighty":-0.683974,"marketCap":6867633},{"date":"2024-08-09","current":-1.111674,"twenty":-1.906237,"median":-1.225937,"eighty":-0.685541,"marketCap":6933267},{"date":"2024-08-16","current":-1.293659,"twenty":-1.846933,"median":-1.234183,"eighty":-0.690721,"marketCap":8068268},{"date":"2024-08-23","current":-1.172164,"twenty":-1.818901,"median":-1.225937,"eighty":-0.699354,"marketCap":7310532},{"date":"2024-08-30","current":-1.264569,"twenty":-1.714964,"median":-1.241521,"eighty":-0.700775,"marketCap":7886837},{"date":"2024-09-06","current":-1.377507,"twenty":-1.706882,"median":-1.245795,"eighty":-0.702272,"marketCap":8591209},{"date":"2024-09-13","current":-1.830972,"twenty":-1.706882,"median":-1.246644,"eighty":-0.711712,"marketCap":11419371},{"date":"2024-09-20","current":-1.918243,"twenty":-1.834164,"median":-1.261146,"eighty":-0.71433,"marketCap":11963659},{"date":"2024-09-27","current":-2.482935,"twenty":-1.908638,"median":-1.273231,"eighty":-0.715692,"marketCap":15485521},{"date":"2024-10-04","current":-1.950755,"twenty":-1.957258,"median":-1.289021,"eighty":-0.720072,"marketCap":12166433},{"date":"2024-10-11","current":-1.928578,"twenty":-1.985498,"median":-1.30307,"eighty":-0.721088,"marketCap":12028120},{"date":"2024-10-18","current":-2.789238,"twenty":-2.037954,"median":-1.318426,"eighty":-0.721575,"marketCap":17395865},{"date":"2024-10-25","current":-2.86453,"twenty":-2.049228,"median":-1.322439,"eighty":-0.722103,"marketCap":17865446},{"date":"2024-10-31","current":-3.933452,"twenty":-2.070731,"median":-1.331376,"eighty":-0.722465,"marketCap":24532076},{"date":"2024-11-08","current":-3.909452,"twenty":-2.133327,"median":-1.338437,"eighty":-0.727802,"marketCap":24382399},{"date":"2024-11-15","current":-3.259855,"twenty":-2.194086,"median":-1.341467,"eighty":-0.734352,"marketCap":24801495},{"date":"2024-11-22","current":-3.282348,"twenty":-2.233732,"median":-1.351028,"eighty":-0.73941,"marketCap":24972628},{"date":"2024-11-29","current":-3.558806,"twenty":-2.265055,"median":-1.353013,"eighty":-0.74173,"marketCap":27075962},{"date":"2024-12-06","current":-3.132405,"twenty":-2.307334,"median":-1.357489,"eighty":-0.742873,"marketCap":23831837},{"date":"2024-12-13","current":-2.717719,"twenty":-2.368619,"median":-1.360113,"eighty":-0.745058,"marketCap":20676837},{"date":"2024-12-20","current":-3.394806,"twenty":-2.438951,"median":-1.363105,"eighty":-0.747693,"marketCap":25828222},{"date":"2024-12-27","current":-3.854006,"twenty":-2.462017,"median":-1.369978,"eighty":-0.749448,"marketCap":29321894},{"date":"2025-01-03","current":-3.631435,"twenty":-2.481224,"median":-1.377507,"eighty":-0.751556,"marketCap":27628533},{"date":"2025-01-10","current":-3.877435,"twenty":-2.523165,"median":-1.379523,"eighty":-0.753182,"marketCap":29500143},{"date":"2025-01-17","current":-4.264007,"twenty":-2.624538,"median":-1.387215,"eighty":-0.756024,"marketCap":32441245},{"date":"2025-01-24","current":-4.636522,"twenty":-2.674136,"median":-1.387903,"eighty":-0.758704,"marketCap":35275397},{"date":"2025-01-31","current":-4.458465,"twenty":-2.840559,"median":-1.398551,"eighty":-0.76167,"marketCap":33920708},{"date":"2025-02-07","current":-4.474865,"twenty":-2.909946,"median":-1.409317,"eighty":-0.766663,"marketCap":34045482},{"date":"2025-02-14","current":-4.49595,"twenty":-2.953876,"median":-1.417578,"eighty":-0.770226,"marketCap":34205906},{"date":"2025-02-21","current":-4.50415,"twenty":-3.001398,"median":-1.420575,"eighty":-0.772831,"marketCap":34268293},{"date":"2025-02-28","current":-4.313207,"twenty":-3.066784,"median":-1.427287,"eighty":-0.777478,"marketCap":32815567},{"date":"2025-03-07","current":-3.912578,"twenty":-3.139979,"median":-1.436606,"eighty":-0.780079,"marketCap":29767516},{"date":"2025-03-14","current":-4.088293,"twenty":-3.197171,"median":-1.445403,"eighty":-0.780934,"marketCap":31104380},{"date":"2025-03-21","current":-3.441281,"twenty":-3.248668,"median":-1.453604,"eighty":-0.782025,"marketCap":36654345},{"date":"2025-03-28","current":-3.301865,"twenty":-3.277995,"median":-1.456931,"eighty":-0.78237,"marketCap":35169374},{"date":"2025-04-04","current":-2.968325,"twenty":-3.266821,"median":-1.464503,"eighty":-0.783762,"marketCap":31616722},{"date":"2025-04-11","current":-2.518311,"twenty":-3.259068,"median":-1.469382,"eighty":-0.787263,"marketCap":26823461},{"date":"2025-04-17","current":-2.85891,"twenty":-3.257859,"median":-1.474662,"eighty":-0.790653,"marketCap":30451302},{"date":"2025-04-25","current":-3.000091,"twenty":-3.257392,"median":-1.49369,"eighty":-0.791084,"marketCap":31955070},{"date":"2025-05-02","current":-2.911853,"twenty":-3.251752,"median":-1.503204,"eighty":-0.791261,"marketCap":31015215},{"date":"2025-05-09","current":-2.270277,"twenty":-3.230283,"median":-1.504138,"eighty":-0.792361,"marketCap":29135505},{"date":"2025-05-16","current":-2.217562,"twenty":-3.211785,"median":-1.51768,"eighty":-0.795364,"marketCap":28458997},{"date":"2025-05-23","current":-2.303286,"twenty":-3.207473,"median":-1.520322,"eighty":-0.798283,"marketCap":29559125},{"date":"2025-05-30","current":-2.048131,"twenty":-3.194675,"median":-1.522232,"eighty":-0.80779,"marketCap":26284611},{"date":"2025-06-06","current":-2.238922,"twenty":-3.17692,"median":-1.535185,"eighty":-0.81143,"marketCap":28733121},{"date":"2025-06-13","current":-2.297156,"twenty":-3.160912,"median":-1.541956,"eighty":-0.811839,"marketCap":29480458},{"date":"2025-06-20","current":-2.051962,"twenty":-3.160912,"median":-1.546017,"eighty":-0.812362,"marketCap":26333778},{"date":"2025-06-27","current":-1.575368,"twenty":-3.148205,"median":-1.553351,"eighty":-0.816087,"marketCap":20217419},{"date":"2025-07-03","current":-1.989132,"twenty":-3.137454,"median":-1.556427,"eighty":-0.819168,"marketCap":25527441},{"date":"2025-07-11","current":-1.992197,"twenty":-3.130448,"median":-1.575368,"eighty":-0.822233,"marketCap":25566775},{"date":"2025-07-18","current":-1.819029,"twenty":-3.122655,"median":-1.585907,"eighty":-0.824111,"marketCap":23344432},{"date":"2025-07-25","current":-1.748536,"twenty":-3.115288,"median":-1.592623,"eighty":-0.830969,"marketCap":22439761},{"date":"2025-08-01","current":-1.596822,"twenty":-3.112066,"median":-1.60755,"eighty":-0.83978,"marketCap":20492753},{"date":"2025-08-08","current":-1.687442,"twenty":-3.09327,"median":-1.615212,"eighty":-0.845488,"marketCap":21655715},{"date":"2025-08-15","current":-1.874525,"twenty":-3.081005,"median":-1.616467,"eighty":-0.850297,"marketCap":26445353},{"date":"2025-08-22","current":-1.806334,"twenty":-3.070504,"median":-1.637011,"eighty":-0.858896,"marketCap":25483332},{"date":"2025-08-29","current":-1.928207,"twenty":-3.05288,"median":-1.651282,"eighty":-0.863774,"marketCap":27202689},{"date":"2025-09-05","current":-1.815039,"twenty":-3.045161,"median":-1.654092,"eighty":-0.866712,"marketCap":25606143},{"date":"2025-09-12","current":-1.958675,"twenty":-3.041134,"median":-1.665783,"eighty":-0.875806,"marketCap":27632529},{"date":"2025-09-19","current":-1.935461,"twenty":-3.028991,"median":-1.685629,"eighty":-0.883586,"marketCap":27305032},{"date":"2025-09-26","current":-2.060236,"twenty":-3.01081,"median":-1.701972,"eighty":-0.884716,"marketCap":29065326},{"date":"2025-10-03","current":-2.058785,"twenty":-2.99162,"median":-1.71336,"eighty":-0.887838,"marketCap":29044858},{"date":"2025-10-10","current":-2.058785,"twenty":-2.977972,"median":-1.730146,"eighty":-0.89028,"marketCap":29044858},{"date":"2025-10-17","current":-2.005828,"twenty":-2.973266,"median":-1.744222,"eighty":-0.89604,"marketCap":28297756},{"date":"2025-10-24","current":-1.997849,"twenty":-2.966913,"median":-1.748536,"eighty":-0.904366,"marketCap":28185179},{"date":"2025-10-31","current":-1.874525,"twenty":-2.963428,"median":-1.767691,"eighty":-0.910735,"marketCap":26445353},{"date":"2025-11-07","current":-1.770062,"twenty":-2.961332,"median":-1.774587,"eighty":-0.921067,"marketCap":24971618},{"date":"2025-11-14","current":-1.657615,"twenty":-2.959148,"median":-1.761439,"eighty":-0.923876,"marketCap":23845849},{"date":"2025-11-21","current":-1.630588,"twenty":-2.955352,"median":-1.753133,"eighty":-0.926618,"marketCap":23457048},{"date":"2025-11-28","current":-1.354629,"twenty":-2.954378,"median":-1.747124,"eighty":-0.930499,"marketCap":19487202},{"date":"2025-12-05","current":-1.601728,"twenty":-2.954068,"median":-1.744222,"eighty":-0.934516,"marketCap":23041879},{"date":"2025-12-12","current":-1.587298,"twenty":-2.950868,"median":-1.73848,"eighty":-0.939656,"marketCap":22834295},{"date":"2025-12-19","current":-1.063489,"twenty":-2.940291,"median":-1.726315,"eighty":-0.940873,"marketCap":15298977},{"date":"2025-12-26","current":-1.063489,"twenty":-2.940291,"median":-1.71823,"eighty":-0.944523,"marketCap":15298977},{"date":"2026-01-02","current":-1.101967,"twenty":-2.938888,"median":-1.708991,"eighty":-0.944976,"marketCap":15852501},{"date":"2026-01-09","current":-1.280752,"twenty":-2.91719,"median":-1.701972,"eighty":-0.952147,"marketCap":18424440},{"date":"2026-01-16","current":-1.332762,"twenty":-2.904794,"median":-1.687875,"eighty":-0.957005,"marketCap":19172641},{"date":"2026-01-23","current":-1.241744,"twenty":-2.899853,"median":-1.679836,"eighty":-0.969272,"marketCap":17863290},{"date":"2026-01-30","current":-1.212489,"twenty":-2.893625,"median":-1.665783,"eighty":-0.98096,"marketCap":17442427},{"date":"2026-02-06","current":-0.867921,"twenty":-2.886524,"median":-1.656007,"eighty":-0.98096,"marketCap":12485598},{"date":"2026-02-13","current":-0.880923,"twenty":-2.881499,"median":-1.651447,"eighty":-0.944863,"marketCap":12672648},{"date":"2026-02-20","current":-1.009324,"twenty":-2.878053,"median":-1.641539,"eighty":-0.941701,"marketCap":14519768},{"date":"2026-02-27","current":-1.362018,"twenty":-2.873859,"median":-1.62773,"eighty":-0.944396,"marketCap":19593504},{"date":"2026-03-06","current":-1.299443,"twenty":-2.8691,"median":-1.617721,"eighty":-0.944749,"marketCap":18693325},{"date":"2026-03-13","current":-1.16698,"twenty":-2.862282,"median":-1.60245,"eighty":-0.948618,"marketCap":16787751},{"date":"2026-03-20","current":-1.132848,"twenty":-2.857498,"median":-1.596822,"eighty":-0.955458,"marketCap":16296745},{"date":"2026-03-27","current":-0.851668,"twenty":-2.854674,"median":-1.589961,"eighty":-0.944749,"marketCap":12251785},{"date":"2026-04-02","current":-0.865491,"twenty":-2.853417,"median":-1.587275,"eighty":-0.939656,"marketCap":11456822},{"date":"2026-04-10","current":-0.941191,"twenty":-2.848599,"median":-1.585719,"eighty":-0.93011,"marketCap":12458880},{"date":"2026-04-17","current":-0.918466,"twenty":-2.823863,"median":-1.582965,"eighty":-0.926432,"marketCap":12158062},{"date":"2026-04-24","current":-1.04724,"twenty":-2.784819,"median":-1.573829,"eighty":-0.927082,"marketCap":13862698},{"date":"2026-05-01","current":-1.551057,"twenty":-2.759024,"median":-1.555271,"eighty":-0.929709,"marketCap":20531907},{"date":"2026-05-08","current":-1.399905,"twenty":-2.724786,"median":-1.551057,"eighty":-0.93011,"marketCap":18531046},{"date":"2026-05-15","current":-1.36454,"twenty":-2.71069,"median":-1.547537,"eighty":-0.931696,"marketCap":16222361},{"date":"2026-05-22","current":-1.338647,"twenty":-2.679763,"median":-1.541956,"eighty":-0.934516,"marketCap":15914536},{"date":"2026-05-29","current":-1.29463,"twenty":-2.668509,"median":-1.537105,"eighty":-0.93958,"marketCap":15391235},{"date":"2026-06-05","current":-1.115971,"twenty":-2.647139,"median":-1.531678,"eighty":-0.939961,"marketCap":13267244},{"date":"2026-06-12","current":-1.043472,"twenty":-2.647139,"median":-1.522232,"eighty":-0.941191,"marketCap":12405335},{"date":"2026-06-18","current":-0.747912,"twenty":-2.638821,"median":-1.519662,"eighty":-0.938314,"marketCap":8891565},{"date":"2026-06-26","current":-0.690009,"twenty":-2.628688,"median":-1.514039,"eighty":-0.929033,"marketCap":8203186},{"date":"2026-07-02","current":-0.7648,"twenty":-2.625072,"median":-1.503718,"eighty":-0.92408,"marketCap":9092342},{"date":"2026-07-10","current":-0.726198,"twenty":-2.614313,"median":-1.503204,"eighty":-0.915436,"marketCap":8633423},{"date":"2026-07-17","current":-0.56214,"twenty":-2.59754,"median":-1.488933,"eighty":-0.902969,"marketCap":6683015},{"date":"2026-07-24","current":-0.489762,"twenty":-2.58972,"median":-1.474662,"eighty":-0.890464,"marketCap":5822541},{"date":"2026-07-31","current":-0.504237,"twenty":-2.586191,"median":-1.473616,"eighty":-0.884716,"marketCap":5994636},{"date":"2026-08-07","current":-0.45116,"twenty":-2.579965,"median":-1.46932,"eighty":-0.880724,"marketCap":5363621},{"date":"2026-08-14","current":-0.448747,"twenty":-2.553613,"median":-1.465148,"eighty":-0.866463,"marketCap":5334939},{"date":"2026-08-21","current":-0.491387,"twenty":-2.514854,"median":-1.460375,"eighty":-0.851932,"marketCap":5672471},{"date":"2026-08-28","current":-0.483661,"twenty":-2.498975,"median":-1.454925,"eighty":-0.838248,"marketCap":5583281},{"date":"2026-09-04","current":-0.395582,"twenty":-2.482251,"median":-1.447445,"eighty":-0.821697,"marketCap":4566517},{"date":"2026-09-11","current":-0.364677,"twenty":-2.481224,"median":-1.445403,"eighty":-0.813391,"marketCap":4209758},{"date":"2026-09-18","current":-0.346134,"twenty":-2.481224,"median":-1.437748,"eighty":-0.810719,"marketCap":3995703},{"date":"2026-09-25","current":-0.370858,"twenty":-2.478828,"median":-1.435696,"eighty":-0.799106,"marketCap":4281110},{"date":"2026-10-02","current":-0.299777,"twenty":-2.467799,"median":-1.431454,"eighty":-0.791261,"marketCap":3460564},{"date":"2026-10-07","current":-0.305958,"twenty":-2.463463,"median":-1.430392,"eighty":-0.789454,"marketCap":3531916}],"updateTime":1791455533905},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVKD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643449782","title":"Cadrenal Therapeutics Chairman, CEO Quang X. Pham disposes of USD 70,947 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2643449782","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643449782?lang=en_us&edition=fundamental","pubTime":"2026-06-16 08:58","pubTimestamp":1781571531,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Chairman, CEO, Interim CFO Quang X. Pham sold 18,124 common shares in open-market transactions from June 11 to June 15.Sales prices averaged $4.12, $3.94, $3.58 across the three trading days.Direct holdings fell to 132,715 shares following the transactions.He also reported 200,000 shares held indirectly through The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL9gJrcT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics Chairman, CEO Quang X. Pham disposes of USD 70,947 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643320950","title":"Cadrenal Therapeutics to initiate CAD-1005 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643320950","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643320950?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:15","pubTimestamp":1781529354,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics (CVKD) announced that it plans to initiate a Phase 2a proof-of-concept clinical trial of its lead drug candidate, CAD-1005, b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-to-initiate-cad-1005-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cadrenal-therapeutics-to-initiate-cad-1005-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","CVKD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643397205","title":"Cadrenal Therapeutics plans Phase 2a trial of CAD-1005 to prevent acute kidney injury in high-risk cardiac surgery patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2643397205","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643397205?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:31","pubTimestamp":1781526666,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics outlined plans to start a Phase 2a proof-of-concept trial of CAD-1005 to prevent acute kidney injury in high-risk cardiac surgery patients.No results have been presented; initial data are expected from the study starting later this year.The trial is designed to generate early safety and kidney-protection signals, supporting partnering talks ahead of BIO 2026.Management expects the readout to also strengthen the investment case for its Phase 3-ready heparin-induced thrombocytopenia program.Cardiac surgery-associated acute kidney injury affects about 35,000 U.S. patients annually; no FDA-approved targeted prevention therapy is available.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL2Zw3sg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4585","SG9999014039.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","BK4007","LU2210150020.SGD","BK4112","SG9999014013.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","LU0314104364.USD","IE00BGHQF748.EUR","CVKD","BK4588","SG9999014021.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205804","title":"Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (Csa-Aki) Clinical Plan to Accelerate Pharma Partnering at Upcoming Bio 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205804","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205804?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA4YX9YG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205803","title":"Cadrenal Therapeutics - to Initiate Phase 2a Trial of CAD-1005 for Aki in Cardiac Surgery Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205803","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205803?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA4YX9YG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643058052","title":"Cadrenal Therapeutics - Phase 2a Trial Expected to Begin Later This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2643058052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643058052?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA4YX9YG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642150472","title":"Cadrenal Therapeutics CEO Quang X. Pham disposes of $90,610 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642150472","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642150472?lang=en_us&edition=fundamental","pubTime":"2026-06-11 08:26","pubTimestamp":1781137618,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics chairman, CEO, interim CFO Quang X. Pham sold 22,385 common shares on June 8-10.Sales were priced at weighted-average $4.38, $4.06, $4.21.Direct holdings fell to 150,839 shares following the transactions.Separately, he reported 200,000 shares held indirectly through the PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLXWt3m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO Quang X. Pham disposes of $90,610 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128533","title":"Cadrenal CEO, Chairman Quang X. Pham sells USD 36,071 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128533","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128533?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:27","pubTimestamp":1780694829,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang X. Pham sold 8,285 common shares in open-market transactions on June 3-5.Sales prices averaged USD 4.26 to USD 4.42 per share.Directly held stake fell to 173,224 shares following the sales.He also reported indirect ownership of 200,000 shares held by The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL8sZ8ZP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal CEO, Chairman Quang X. Pham sells USD 36,071 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640718295","title":"BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640718295","media":"Reuters","labels":["executive","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640718295?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:34","pubTimestamp":1780522462,"startTime":"0","endTime":"0","summary":"BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC FilingJune 3  - Cadrenal Therapeutics Inc CVKD.O:CADRENAL THERAPEUTICS - MATTHEW K. SZOT STEPS DOWN AS CFO EFFECTIVE MAY 28, 2026 - SEC FILINGCADRENAL THERAPEUTICS - APPOINTS QUANG X. PHAM AS INTERIM CFO AND INTERIM PRINCIPAL ACCOUNTING OFFICER - SEC FILINGSource text: [ID:n0001213900-26-064744]Further company coverage: CVKD.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640181470","title":"Cadrenal Therapeutics - Appoints Quang X. Pham as Interim CFO and Interim Principal Accounting Officer - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640181470","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640181470?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:26","pubTimestamp":1780518393,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0XW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640181405","title":"Cadrenal Therapeutics - Matthew K. Szot Steps Down as CFO Effective May 28, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2640181405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640181405?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:26","pubTimestamp":1780518393,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nFWN42B0XW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640218140","title":"Cadrenal Therapeutics names CEO Quang X. Pham interim CFO after Matthew Szot exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2640218140","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640218140?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:26","pubTimestamp":1780518386,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics named CEO Quang X. Pham interim CFO and interim principal accounting officer, effective immediately.Matthew K. Szot stepped down as CFO on May 28, 2026; the company started a search for a permanent replacement.Pham founded Cadrenal; he previously led Espero BioPharma as CEO and chairman and earlier worked as a partner at D+R LATHIAN.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL8tJb5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640490279","title":"Cadrenal Therapeutics to attend BIO International Convention 2026 partnering event","url":"https://stock-news.laohu8.com/highlight/detail?id=2640490279","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640490279?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:22","pubTimestamp":1780492946,"startTime":"0","endTime":"0","summary":"Cadrenal will attend the BIO International Convention 2026 Partnering Event in San Diego on June 22-25, 2026.Management plans partnering meetings to discuss development and commercialization options for CAD-1005, a Phase 3-ready 12-LOX inhibitor for HIT.Talks will also cover tecarfarin, a late-stage oral anticoagulant with FDA Orphan Drug and Fast Track designations in ESRD-AFib, LVAD patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL3XfNht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640924722","title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 3,057.57 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2640924722","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640924722?lang=en_us&edition=fundamental","pubTime":"2026-06-03 08:34","pubTimestamp":1780446892,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang X. Pham sold 652 shares of common stock in late May and early June.Sales priced at USD 5.01 on May 29, 2026, USD 4.46 on June 2, 2026.Directly held stake fell to 181,509 shares following the June 2 sale.He also reported 200,000 shares held indirectly through The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL5nrs89:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 3,057.57 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639677513","title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 69,363 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2639677513","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639677513?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:33","pubTimestamp":1780086812,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang X. Pham sold 12,763 common shares in May at weighted-average prices of $4.93 to $5.76.Direct holdings fell to 182,161 shares following the latest sale on May 28.He also reported 200,000 shares held indirectly through The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL8Bt9rB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO, Chairman Quang X. Pham sells USD 69,363 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638241355","title":"Cadrenal Therapeutics CEO, Chairman Quang Pham sells 1,165 common shares for $6,628.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2638241355","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638241355?lang=en_us&edition=fundamental","pubTime":"2026-05-27 09:07","pubTimestamp":1779844041,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics CEO and Chairman Quang Pham sold 1,165 common shares on May 22, 2026 at a weighted average USD 5.69.Direct holdings fell to 194,924 shares following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL2xfdkj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics CEO, Chairman Quang Pham sells 1,165 common shares for $6,628.85","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636986424","title":"Cadrenal Therapeutics to present at Lytham Partners Spring 2026 Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636986424","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636986424?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:31","pubTimestamp":1779222711,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics will present at the virtual Lytham Partners Spring 2026 Investor Conference on May 28, 2026.The webcast presentation is scheduled for 9:30 a.m. ET.Management will also hold virtual one-on-one investor meetings during the May 28 event.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL33BgQ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","BK4007","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD","LU2210149790.SGD","NDAQ","BK4112","LU0314104364.USD","CVKD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014021.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468381","title":"Cadrenal Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468381","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468381?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:29","pubTimestamp":1778254197,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryCadrenal Therapeutics Inc CVKD.OQ reported a quarterly adjusted loss of $1.04 per share for the quarter ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142286","title":"Press Release: Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142286","media":"Dow Jones","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142286?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:30","pubTimestamp":1778157000,"startTime":"0","endTime":"0","summary":"PONTE VEDRA, Fla., May 07, 2026  -- Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results for the first quarter ended March 31, 2026, and provided a corporate update highlighting continued progress in its CAD-1005 program for HIT. The Company has now received the official minutes from its End-of-Phase 2  meeting with the U.S. Food and Drug Administration , which provided guidance on key elements of the planned pivotal Phase 3 registration trial for CAD-1005, Cadrenal's investigational first-in-class 12-lipoxygenase  inhibitor being developed to treat suspected heparin-induced thrombocytopenia . Based on this feedback and Phase 2 data, Cadrenal plans to advance directly to a randomized, blinded, placebo-controlled Phase 3 study evaluating CAD-1005 added to standard-of-care anticoagulation in patients with HIT.-- Received official FDA EOP2 meeting minutes p","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6505","BK4585","HIT","BK4173","LENZ","BK4139","BK4588","BK4007","N0Z.SI","BK4539","BK6096","CVKD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955244","title":"Cadrenal Therapeutics Inc  expected to post a loss of $1.62 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955244","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955244?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:11","pubTimestamp":1777900268,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics Inc  expected to post a loss of $1.62 a share - Earnings Preview Cadrenal Therapeutics Inc CVKD.OQ CVKD.O is expected to  show no change in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nL8N41H19E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CVKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":71,"code":"91000000","status":"200"}]}}